{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:01:06Z","timestamp":1777550466108,"version":"3.51.4"},"reference-count":14,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":904,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transbound Emerg Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/tbed.12069","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T01:56:12Z","timestamp":1363139772000},"page":"e89-e91","source":"Crossref","is-referenced-by-count":17,"title":["Proof of Concept for the Inhibition of Foot-and-Mouth Disease Virus Replication by the Anti-Viral Drug 2\u2032-<i>C<\/i>-Methylcytidine in Severe Combined Immunodeficient Mice"],"prefix":"10.1155","volume":"61","author":[{"given":"D. J.","family":"Lefebvre","sequence":"first","affiliation":[{"name":"Unit of Vesicular and Exotic Diseases; Virology Department; CODA-CERVA; Veterinary and Agrochemical Research Centre; Brussel Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"De Vleeschauwer","sequence":"additional","affiliation":[{"name":"Unit of Vesicular and Exotic Diseases; Virology Department; CODA-CERVA; Veterinary and Agrochemical Research Centre; Brussel Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Goris","sequence":"additional","affiliation":[{"name":"Okapi Sciences N.V.; Heverlee Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kollanur","sequence":"additional","affiliation":[{"name":"Okapi Sciences N.V.; Heverlee Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Billiet","sequence":"additional","affiliation":[{"name":"Okapi Sciences N.V.; Heverlee Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Murao","sequence":"additional","affiliation":[{"name":"Okapi Sciences N.V.; Heverlee Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Neyts","sequence":"additional","affiliation":[{"name":"Okapi Sciences N.V.; Heverlee Belgium"},{"name":"Laboratory of Virology and Experimental Chemotherapy; Rega Institute for Medical Research; University of Leuven (KU Leuven); Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"De Clercq","sequence":"additional","affiliation":[{"name":"Unit of Vesicular and Exotic Diseases; Virology Department; CODA-CERVA; Veterinary and Agrochemical Research Centre; Brussel Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,3,11]]},"reference":[{"key":"10.1111\/tbed.12069-BIB0001|tbed12069-cit-0001","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/JVI.80.7.3559-3566.2006","article-title":"Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo","volume":"80","author":"Chen","year":"2006","journal-title":"J. Virol."},{"key":"10.1111\/tbed.12069-BIB0002|tbed12069-cit-0002","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1021\/jm0502788","article-title":"Design, synthesis, and antiviral activity of 2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine, a potent inhibitor of hepatitis C virus replication","volume":"48","author":"Clark","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1111\/tbed.12069-BIB0003|tbed12069-cit-0003","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/jir.2012.0012","article-title":"Novel antiviral therapeutics to control foot-and-mouth disease","volume":"32","author":"Dias","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1111\/tbed.12069-BIB0004|tbed12069-cit-0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-3542(98)00038-2","article-title":"Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice","volume":"39","author":"Duan","year":"1998","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0005|tbed12069-cit-0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0006|tbed12069-cit-0006","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","article-title":"Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7\u00a0days and partial protection in 4\u00a0days: use in emergency outbreak response","volume":"23","author":"Golde","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12069-BIB0007|tbed12069-cit-0007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2\u2032-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0008|tbed12069-cit-0008","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0009|tbed12069-cit-0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jviromet.2009.05.005","article-title":"Validation of two real-time RT-PCR methods for foot-and-mouth disease diagnosis: RNA-extraction, matrix effect, uncertainty of measurement and precision","volume":"160","author":"Goris","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1111\/tbed.12069-BIB0010|tbed12069-cit-0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.antiviral.2010.03.004","article-title":"Efficacy of 2\u2032-C-methylcytidine against yellow fever virus in cell culture and in a hamster model","volume":"86","author":"Julander","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0011|tbed12069-cit-0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2012.09.009","article-title":"Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-\u03b1 and antiviral agents","volume":"96","author":"Kim","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12069-BIB0012|tbed12069-cit-0012","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1865-1682.2010.01169.x","article-title":"Development of a foot-and-mouth disease infection model in severe combined immunodeficient mice for the preliminary evaluation of antiviral drugs","volume":"57","author":"Lefebvre","year":"2010","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1111\/tbed.12069-BIB0013|tbed12069-cit-0013","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1128\/JVI.06683-11","article-title":"Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle","volume":"86","author":"Perez-Martin","year":"2012","journal-title":"J. Virol."},{"key":"10.1111\/tbed.12069-BIB0014|tbed12069-cit-0014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prevetmed.2012.03.002","article-title":"Classical swine fever outbreak containment using antiviral supplementation: a potential alternative to emergency vaccination and stamping-out","volume":"106","author":"Ribbens","year":"2012","journal-title":"Prev. Vet. Med."}],"container-title":["Transboundary and Emerging Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftbed.12069","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tbed.12069\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T15:44:02Z","timestamp":1675957442000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbed.12069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/tbed.12069","relation":{},"ISSN":["1865-1674"],"issn-type":[{"value":"1865-1674","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,11]]}}}